ondansetron has been researched along with itasetron in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algate, DR; Bonali, P; Donetti, A; Micheletti, R; Montagna, E; Nicola, M; Rimoldi, EM; Sagrada, A; Schiantarelli, P; Turconi, M | 1 |
| Egerer, G; Goldschmidt, H; Kempe, R; Salwender, H; Voigt, T | 1 |
1 trial(s) available for ondansetron and itasetron
| Article | Year |
|---|---|
Comparison of oral itasetron with oral ondansetron: results of a double-blind, active-controlled phase II study in chemotherapy-naive patients receiving moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Benzimidazoles; Biological Availability; Bridged Bicyclo Compounds, Heterocyclic; Double-Blind Method; Humans; Middle Aged; Neoplasms; Ondansetron; Vomiting | 1997 |
1 other study(ies) available for ondansetron and itasetron
| Article | Year |
|---|---|
Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation.
Topics: Animals; Antiemetics; Benzimidazoles; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Female; Ferrets; Imidazoles; Male; Metoclopramide; Neoplasms, Experimental; Ondansetron; Serotonin Antagonists; Time Factors; Vomiting | 1991 |